10x Genomics Inc (TXG) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
10x Genomics Inc   (NASDAQ: TXG)


10x Genomics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TXG Gross Profit Margin (Sep 30 2026)
Q3 		(Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3
Y / Y Revenue Change 1.59 %
Seq. Revenue Change -0.24 %
Revenue In Millions $150.67
Gross Profit Margin 74.95 %
Gross Profit Margin Total Ranking # 992
Gross Profit In Millions $112.93
Y / Y Gross Profit Change 12.58 %
Seq. Gross Profit Change 0.38 %


Commenting Third Quarter 2026 Gross Profit Margin
10x Genomics Inc achieved Gross Profit of $113 millions compare to Gross Loss of $112.50 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q3 of -0.24 % 10x Genomics Inc managed to reduce Cost of Sales and increase Gross Profit by 0.38 % to $113 millions. Gross Profit Margin grew to 74.95 %, below company average Gross Profit Margin.


Observing third quarter 2026 results within Laboratory Analytical Instruments industry 10x Genomics Inc has achieved highest Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 992, from total ranking in the previous quarter at 1181.
Learn about Gross Margin
TXG's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 1
Healthcare Sector # 177
Overall # 983

Gross Profit Margin Statistics
High Average Low
95.76 % 75.13 % 62.22 %
(Jun 30 2021)   (Sep 30 2023)


TXG Gross Income Trends • More of TXG's Profitabilty Ratios • TXG Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
TXG's Cumulative Gross Profit Margin
Laboratory Analytical Instruments Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
TXG's Gross Profit Margin Profitability versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for TXG's Competitors
Gross Profit Margin Profit Margin for 10x Genomics Inc 's Suppliers
Gross Profit Margin Profit Margin for TXG's Customers

You may also want to know
TXG's Annual Growth Rates TXG's Profitability Ratios TXG's Asset Turnover Ratio TXG's Dividend Growth
TXG's Roe TXG's Valuation Ratios TXG's Financial Strength Ratios TXG's Gross Profit Growth
TXG's Roa TXG's Inventory Turnover Ratio TXG's Growth Rates TXG's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2026, within Laboratory Analytical Instruments Industry Gross Profit MarginSep 30 2026 MRQ Gross ProfitSep 30 2026 MRQ Revenue
Nautilus Biotechnology Inc   89.74 %$ 0.210  Millions$ 0.234  Millions
10x Genomics Inc   74.95 %$ 112.927  Millions$ 150.667  Millions
Illumina Inc   73.52 %$ 830.000  Millions$ 1,129.000  Millions
Alamar Biosciences Inc   61.54 %$ 20.644  Millions$ 33.545  Millions
Mettler toledo International Inc   59.79 %$ 654.224  Millions$ 1,094.294  Millions
Cytek Biosciences Inc   58.63 %$ 31.206  Millions$ 53.229  Millions
Revvity Inc  57.43 %$ 418.579  Millions$ 728.899  Millions
Standard Biotools Inc   55.86 %$ 10.828  Millions$ 19.385  Millions
Harvard Bioscience Inc   55.45 %$ 12.307  Millions$ 22.196  Millions
Bio rad Laboratories Inc   50.06 %$ 328.600  Millions$ 656.400  Millions
Bruker Corporation  49.12 %$ 429.300  Millions$ 874.000  Millions
Bionano Genomics Inc   47.72 %$ 3.949  Millions$ 8.276  Millions
Seer Inc   47.20 %$ 1.879  Millions$ 3.981  Millions
Precipio inc   46.08 %$ 3.378  Millions$ 7.331  Millions
Quanterix Corporation  38.60 %$ 13.500  Millions$ 34.974  Millions
Pacific Biosciences Of California Inc   33.21 %$ 13.470  Millions$ 40.564  Millions
Avantor Inc   31.49 %$ 534.800  Millions$ 1,698.300  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.